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A B S T R A C T
Background
Interleukin (IL)-32 is a newly described proinflammatory cytokine that seems likely to play a 
role in inflammation and host defense. Little is known about the regulation of IL-32 production 
by primary cells of the immune system.
Methods and Findings
In the present study, freshly obtained human peripheral blood mononuclear cells were 
stimulated with different Toll-like receptor (TLR) agonists, and gene expression and synthesis of 
IL-32 was determined. We demonstrate that the TLR4 agonist lipopolysaccharide induces 
moderate (4-fold) production of IL-32, whereas agonists of TLR2, TLR3, TLR5, or TLR9, each of 
which strongly induced tumor necrosis factor a and IL-6, did not stimulate IL-32 production. 
However, the greatest amount of IL-32 was induced by the mycobacteria Mycobacterium 
tuberculosis and M. bovis BCG (20-fold over unstimulated cells). IL-32-induced synthesis by 
either lipopolysaccharide or mycobacteria remains entirely cell-associated in monocytes; 
moreover, steady-state mRNA levels are present in unstimulated monocytes without translation 
into IL-32 protein, similar to other cytokines lacking a signal peptide. IL-32 production induced 
by M. tuberculosis is dependent on endogenous interferon-y (IFNy); endogenous IFNy is, in turn, 
dependent on M. tuberculosis-induced IL-18 via caspase-1.
Conclusions
In conclusion, IL-32 is a cell-associated proinflammatory cytokine, which is specifically 
stimulated by mycobacteria through a caspase-1- and IL-18-dependent production of IFNy.
The Editors' Summary of this article follows the references.
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Introduction
Interleukin (IL)-32 is a recently described cytokine initially 
thought to be a product o f T, natural killer, and epithelial 
cells. The cytokine exhibits several properties o f a classical 
proinflammatory m ediator [1]. For example, IL-32 induces 
the production o f tum or necrosis factor (TNF) a, IL-8, and 
MIP-2 via the activation o f NF-kB and p38 MAP kinase [1]. In 
addition, maturation ofIL-1P through a caspase-1-dependent 
mechanism is also a property o f IL-32 [2]. These proin- 
flammatory effects o f IL-32 suggest an im portant role o f IL- 
32 in inflamm ation and antibacterial defense.
In macrophages infected with intracellular pathogens, 
activation by interferon-y (IFNy) in com bination with TNF 
is a major effector mechanism o f cell-m ediated immunity [3]. 
IFNy induces antimicrobial killing mechanisms in monocytes, 
macrophages, and neutrophils, by activating phagocytosis, 
stimulating oxygen radical production, and activating the 
synthesis o f the inducible form o f NO [4,5]. The crucial role 
o f these IFNy properties for host antimicrobial defense has 
been dem onstrated in patients with defects in either IFNy or 
IL-12 receptors [6,7]. These patients have increased suscept­
ibility to intracellular microorganisms such as mycobacteria 
and salmonella species [6,7]. Infection with atypical mycbo- 
bacteria such as non-tuberculous mycobacteria or Mycobacte­
rium bovis BCG is particularly dangerous in patients lacking 
adequate IFNy production and is a main factor determ ining  
the long-term  prognosis o f these patients [8].
Because o f the proinflammatory effects o f IL-32 and its 
induction from  epithelial cell lines by IFNy [1], we wanted to 
determ ine whether IL-32 is produced from  primary cells o f 
the im mune system in response to stim ulation with mycobac­
teria. We investigated the stim ulation o f IL-32 synthesis by 
several agonists o f TLR, as well as bacterial pathogens. In the 
present study, we also define the IFNy-dependent pathway o f 
M. tuberculosis-induced  IL-32 from  peripheral b lood m ono­
nuclear cells (PBMCs).
Methods
Reagents and Microorganisms
Synthetic Pam3Cys was purchased from  EMC M icrocollec­
tions (Tubingen, Germany). Lipopolysaccharide (LPS) (Escher­
ichia coli serotype 055:B5) and poly I:C were purchased from  
Sigma Chemical (St. Louis, Missouri, U nited States). H37Rv 
and M. bovis BCG w ere grow n to m id -log  phase in 
M iddlebrook 7H9 liquid medium supplem ented with oleic 
acid, albumin, dextrose, and catalase (Difco Laboratories, 
Sparks, Maryland, U nited States), washed three times in 
sterile saline, and resuspended in RPMI 1640 medium. 
Separate culture suspensions were sonicated for 10 min on 
ice, in order to obtain noninfective cell lysates. Cultures o f 
Staphylococcus aureus were grown in basic medium broth (Luria 
broth supplem ented with 0.1% K2HPO4 and 0.1% glucose), 
washed in sterile saline, and resuspended in RPMI 1640 
medium, as described above.
Stimulation of Whole Blood Cultures w ith Mycobacteria
After inform ed consent, venous b lood was drawn from  the 
antecubital vein o f eight healthy volunteers into heparin  
tubes. Then 750 i l  o f either RPMI culture medium or RPMI 
containing sonicated M. tuberculosis or BGC (both at a 
concentration o f 10 ig/m l) was added to 4.0-ml screw cap
PLoS Medicine | www.plosmedicine.org 1311
cryogenic tubes (Corning, Corning, New York, U nited  
States). Thereafter, 250 i l  o f freshly obtained heparinized  
blood was added to tubes containing stimuli. The tubes were 
capped tightly and incubated at 37 °C in an upright position. 
After 24 h o f incubation, the b lood was m ixed by rapid 
vortex and transferred into 1.5-ml Eppendorf tubes (Brink­
mann Instruments, Westbury, New York, U nited States). 
Triton X-100 (Bio-Rad Laboratories, Hercules, California, 
U nited States) was then added (0.5% final concentration) 
and the blood mixed until lysed. The lysed blood was stored 
at —70 °C until assay. In these whole b lood  cultures, 
intracellular and secreted cytokine concentrations were 
determ ined together, and the results represent ‘‘total’’ 
cytokine production.
Isolation o f PBMCs and Stimulation o f Cytokine 
Production
The PBMC fraction was obtained by density centrifugation  
o f b lood diluted 1:1 in pyrogen-free saline over Histopaque 
(Sigma, St. Louis, Missouri, U nited States). Cells were washed 
twice in saline and suspended in culture medium (RPMI 1640) 
supplem ented with penicillin (100 U/ml) and streptomycin  
(100 ig/m l).
To flat-bottom  96-well plates were added 5 X 105 PBMCs in 
a 100-il volume, which was then incubated with either 100 i l  
o f culture medium (negative control) or 100 i l  o f the various 
stimuli: synthetic Pam3Cys lipopeptide (5 ig/m l), poly I:C (5 
ig/m l), E. coli LPS (100 ng/ml), or 1 X 107 heat-killed  
microorganism s/m illiliter o f M. tuberculosis, M. bovis BCG, or 
S. aureus. Each Toll-like receptor (TLR) ligand, except LPS, 
was checked for the presence o f LPS in the LAL assay and 
found to be negative. After 24 h o f incubation at 37 °C, 
supernatants were removed in som e experim ents. Otherwise, 
the cells were lysed by 1% Triton X-100 and two cycles o f 
freeze-thaw. Intracellular and secreted cytokine concentra­
tions were determ ined together, and the results represent 
‘‘total’’ cytokine production. In additional experim ents, the 
effect o f a caspase-1 inhibitor (20 iM  o f Ac-Tyr-Val-Ala-Asp- 
2,6-dimethylbezoyloxymethylketone, YVAD, Alexis Biochem ­
icals, San Diego, California, U nited States), IL-1 receptor  
antagonist (IL-1Ra, 10 ig/m l, R&D Systems, M inneapolis, 
M innesota, U nited States), or IL-18 binding protein (10 ig/m l)
[9] on the M. tuberculosis-induced production o f IL-32 was 
investigated.
In order to test whether the m onocyte or lym phocyte 
population was the source o f IL-32 after stim ulation with 
mycobacteria, PBMCs were incubated for 2 h at 37 °C. The 
nonadherent cells, transferred into another well, were mostly 
lymphocytes, whereas the adherent cells were more than 90% 
monocytes. The stimulation o f IL-32 by the mycobacteria was 
compared between m onocytes and lymphocytes.
Production o f IL-32 stimulated by mycobacteria was also 
investigated in m onocyte-derived macrophages and dendritic 
cells (DCs). Adherent m onocytes were incubated in RPMI for 
5 d in the presence o f either 20% heat-inactivated human  
serum for macrophage differentiation, or a com bination of 
50 ng/ml GM-CSF (Peprotech, Rocky Hill, New Jersey, U nited  
States) plus 20 ng/ml IL-4 (Peprotech) used for DC differ­
entiation. After 5 d, the cells were washed, and the m acro­
phages or DCs were stimulated for an additional 24 h with 
either M. tuberculosis or M. bovis BCG.
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Table 1. Primer Sequences Used in the RT-PCR for the Four 
Isoforms of IL-32
Isoform Primer Sequence
a  and ß F o r w a r d  5 '-CTG AAGGCC CGA ATG CAC CAG-3'
R e v e r s e  5' -GCA AAG GTG GTG TCA GTA T C -3 '  
c F o r w a r d  5 '-GTA ATG CTC CTC CCT ACT T C -3 '
R e v e r s e  5' -GCA AAG GTG GTG TCA GTA T C -3 '
8 F o r w a r d  5 ' -T C T  CTG GTG ACA TGA AGA AGC T - 3 '
R e v e r s e  5' -GCA AAG GTG GTG TCA GTA T C -3 '
DOI: 10.1371/journal.pmed.0030277.t001
Cytokine Measurements
TNFa, IL-6, and IFNy concentrations were determ ined by 
specific electrochem ilum inescence (ECL) assays, as previously 
described [10]. A specific ECL assay was developed for the 
m easurem ent o f  IL-32. The IgG fraction o f polyclonal 
antibodies produced in goats against recom binant human 
IL-32a was purified with Econo-Pac (Cooper, Boynton Beach, 
Florida, U nited States). This IgG fraction was then affinity 
purified using IL-32a im m obilized on Affi-gel 15 agarose 
beads (Bio-Rad Laboratories). O ne aliquot o f the affinity- 
purified anti-IL-32a antibody was labeled with biotin, and 
another aliquot with ruthenium according with the manu­
facturer’s instructions (BioVeris, Gaithersburg, Maryland, 
United States). A standard curve was constructed using 
recom binant human IL-32a (Peprotech). For the assay, 25 i l  
o f a sample or standard was added to 5-ml polypropylene 
tubes (Becton Dickinson, Franklin Lakes, New Jersey, United  
States) and incubated with dilutions o f the biotinylated and 
the ruthenylated antibodies for a total aqueous phase o f 100 
i l  and 25 i l  o f Dynabeads (BioVeris). After shaking at room  
tem perature for 4 h, the reaction was term inated with 200 i l  
o f phosphate-buffered saline (PBS). The electrochem ilum i- 
nescent signal was measured using an Origen Analyzer 
(BioVeris), and the concentrations o f IL-32 were calculated 
from the standard curve generated for each assay. In over ten  
assays, the ECL assay for IL-32 detected from  3 pg/ml to 2,000 
pg/ml. Because o f the polyclonal nature o f the goat antibodies 
and the overlapping amino acids o f the four IL-32 isoforms, 
all isoforms o f IL-32 were likely detected in the ECL assay.
RT-PCR for the IL-32 Isoforms
Ten m illion freshly isolated PBMCs were stimulated with 
either culture medium, 100 ng/ml LPS, or 1 X 10 heat-killed  
M. tuberculosis. After 4 h incubation at 37 °C, total RNA was 
extracted in 1 ml o f TRIzol reagent (Invitrogen, Carlsbad, 
California, U nited States), an improved single-step RNA 
iso la tion  m ethod  based on the m ethod  described  by 
Chomczynski and Sacchi [11]. In addition, RNA was also 
isolated from  an aliquot o f freshly obtained PBMCs, without 
any culture or stimulation. Thereafter, RNA was precipitated  
with isopropanol, washed with 70% ethanol, and dissolved in 
water. Isolated RNA was treated with DNase before being  
reverse transcribed into com plem entary DNA using oligo(dT) 
primers and MMLV reverse transcriptase. PCR was per­
form ed using a Peltier Thermal Cycler-200 (Watertown, 
Massachusetts, U nited States). Primer sequences for the IL- 
32 isoforms are presented in Table 1: one set o f primers
detected both isoform  a and b, whereas two different sets of 
primers detected isoforms y and 8. GAPDH was used as a 
reference gene, for which the primers were 5'-GGC AAA TTC 
AAC GGC ACA-'3 (forward) and 5'-GTT AGT GGG GTC 
TCG CTC TG-'3 (reverse). PCR conditions were as follows: 2 
min at 50 °C and 10 min at 95 °C, follow ed by 30 cycles o f PCR 
reaction at 94 °C for 45 s, 70 °C for 2 min, and 59 °C for 1 min. 
The PCR products were run on 1% agarose gels stained with 
ethidium  bromide.
Immunostaining
Two distinct methods were used for im m unostaining, 
confocal microscopy, and optical microscopy. For confocal 
microscopy, human PBMCs were isolated and cultured on  
eight-chamber glass slides (Nalge Nunc International, N aper­
ville, Illinois, U nited  States) at 37 °C in a hum idified  
atm osphere o f 5% CO2. After the cells were exposed to 
appropriate incubation conditions, they were fixed in 70% 
acetone and 30% methanol for 5 min and washed in PBS. 
Then the cells were fixed in 4% paraformaldehyde for 10 min 
at room  tem perature and washed with PBS. The fixed cells 
were permeabilized in PBS containing 5% donkey normal 
serum for 30 min at room  temperature. This was followed by 
exposure to the primary mouse anti-human IL-32 m ono­
clonal IgG1 antibody at 4 °C overnight. As negative control, 
mouse IgG1 was used instead o f the anti-IL-32 antibody. After 
being washed in PBS, the cells were counterstained with the 
secondary donkey anti-m ouse antibody linked to fluorescein- 
labeled Cy3 (1:150, red), wheat germ agglutinin (5 ig/m l, 
green for cell surface staining), and AMCA(33342) (50 pl/ml, 
blue) for 45 min at room  temperature. Then the slides were 
m ounted with aqueous antiquenching medium. The PBMCs 
were examined by digital deconvoluted microscopy.
For optical microscopy, PBMCs were isolated and stim u­
lated for 24 h in the presence o f culture medium, LPS (100 ng/ 
ml), or heat-killed M. tuberculosis (10 ig/m l) using TEFLON- 
PFA six-well form at culture disks (Savillex, Minnetonka, 
M innesota, U nited States) to avoid adherence o f the PBMCs. 
After 24 h, cytospins o f the stimulated cells were prepared 
and stained with the m onoclonal anti-IL-32 antibody (MoAb, 
clone 9). The primary antibody (5 mg/ml) was diluted (1:500) 
and incubated for 30 min with the tissue sections, followed by 
rabbit anti-m ouse HRPO (1:200, Dako, Glostrup, Denmark) 
for 60 min. The slides were then sequentially incubated with 
the chrom ogen (DAB) reagent for 10 min, counterstained  
w ith Mayer’s hem atoxylin , and m ounted  in perm ount. 
Negative control staining was perform ed using mouse IgG1 
isotype antibody. A Leica (Wetzlar, Germany) m icroscope 
(DMRD model) equipped with a digital camera was used to 
prepare the microphotographs.
Statistical Analysis
The human experim ents were perform ed in duplicate with 
blood obtained from  eight volunteers. The differences  
between groups were analyzed by M ann-W hitney U  test. The 
data are given as means ±  standard error o f the mean (SEM).
Results
Stimulation o f IL-32 by Mycobactyeria
W hole blood diluted one in four with RPMI was stimulated  
with 10 ig /m l heat-killed M. tuberculosis or M. bovis BCG. After
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Figure 1. Stimulation of IL-32 by Mycobacteria
(A) Whole blood was diluted 1:4 with RPMI and stimulated with 10 ig /m l sonicated M. tuberculosis (MTB) or M. bovis BCG (BCG). Triton X-100 (0.5%) was 
added 24 h later, and IL-32 concentration was measured by ECL.
(B) Stimulation of freshly isolated PBMCs with various concentrations of LPS or sonicated M. tuberculosis stimulated IL-32 synthesis in a dose-dependent 
manner.
(C and D) Freshly isolated PBMCs were stimulated with TLR4 (LPS, 100 ng/ml), TLR2 (Pam3Cys, 10 ig /m l), TLR3 (poly I:C, 5 ig /m l), M. tuberculosis, M. 
bovis BCG, or S. aureus (all at 1 X 107 microorganisms/milliliter, heat-killed). After 24 h of stimulation, LPS-, M. tuberculosis-, and M. bovis BCG-stimulated 
production of IL-32 (C) or IL-6 (D) was measured by ECL.
Data are presented as means 6  SEM (n =  8).
DOI: 10.1371/journal.pmed.0030277.g001
24 h, there was significant stim ulation o f IL-32 as measured in 
the total cell lysate o f these cultures (Figure 1A). The level o f 
IL-32 in the lysates o f  w hole b lood  cultures w ithout 
stimulation was less than 5 pg/ml, whereas M. tuberculosis 
and M. bovis BCG increased total IL-32 synthesis over 30-fold.
As shown in Figure 1B, a dose-dependent stimulation o f IL- 
32 release was observed when freshly isolated PBMCs were 
stimulated with M. tuberculosis. Interestingly, LPS also stimu­
lated moderate amounts o f IL-32 in PBMCs in a dose- 
dependent fashion, but these amounts were clearly lower 
than those induced by M. tuberculosis (Figure 1B). In contrast, 
stimulation with other TLR agonists such as Pam3Cys (TLR2) 
and poly I:C (TLR3) did not induce IL-32, despite increm ental 
stimulations with concentrations o f the stimuli up to 100 ig /  
ml (Figure 1C and data not shown). The TLR agonists flagellin  
(TLR5) and CpG (TLR9) did not induce IL-32 either (data not 
shown). Similarly, stim ulation o f PBMCs with other heat- 
killed microorganisms such as S. aureus (shown in Figure 1C), 
Candida albicans, or Aspergillus fumigatus (data not shown) did 
not stimulate IL-32 production. In contrast, all the TLR 
agonists and microorganisms described above were potent 
inducers o f IL-6 (Figure 1D) and TNF (not shown) produc­
tion, in ranges similar to those induced by M. tuberculosis or 
LPS.
Unlike PBMC cultures, whole blood cultures contain all the 
plasma com ponents including antibodies and m acrom ole­
’ PLoS Medicine | www.plosmedicine.org
cules such as com plem ent com ponents and anti-proteases. 
Whereas PBMCs are com posed o f 10%-15% monocytes and 
mostly lymphocytes, whole blood cultures contain 60%-70%  
neutrophils, few m onocytes (4% -6% ), and about 20% 
lymphocytes. W hen com paring total IL-32 production stimu­
lated with either M. tuberculosis or M. bovis BCG, whole blood  
cultures produced 136 pg per m illion monocytes, whereas in 
PBMC cultures, 420 pg were produced per m illion monocytes.
IL-32 Induced by Inflammatory Stimuli Is a Cell-Associated 
Cytokine
W hen hum an PBMCs were stim ulated with 1 X  107 
microorganism s/m illiliter o f heat-killed M . tuberculosis, nearly 
all IL-32 measured was found in the cell-associated fraction  
and not the supernatant medium (Figure 2A). IL-32 was not 
detectable in freshly lysed PBMCs or in PBMCs incubated for 
24 h without added stimulants. However, as shown in Figure 
2B, steady-state levels o f mRNA for IL-32P, IL-32y, and IL-328 
are present in freshly isolated PBMCs without adherence to 
culture vessels. Levels o f IL-32a are low but present. After 4 h 
o f incubation with RPMI only, the levels o f mRNA coding for 
each o f the isoforms remained unchanged (Figure 2B). U pon  
stimulation with LPS for 24 h, there were markedly increased  
levels o f IL-32a and IL-32y, but little change in IL-32P and IL- 
328 (Figure 2B).
As shown in Figure 3A, im m unostaining with a m onoclonal 
mouse anti-human IL-32 antibody also shows the absence o f
August 2006 | Volume 3 | Issue 8 | e2771313
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Figure 2. IL-32 Induced by Inflammatory Stimuli Is a Cell-Associated 
Cytokine
(A) Human PBMCs were stimulated w ith 10 ig /m l sonicated M. 
tuberculosis. After 24 h, supernatants and cell lysates were assayed for 
IL-32 (see Methods).
(B) RT-PCR of the four IL-32 isoforms in freshly lysed PBMCs (lanel), 
PBMCs incubated in medium for 4 h (lane 2), stimulated with 100 ng/ml 
LPS (lane 3), or with M. tuberculosis (lane 4).
DOI: 10.1371/journal.pmed.0030277.g002
IL-32 protein in PBMC cultures after 24 h without added 
stimulants (Figure 3A, upper lane, and Figure 3B, left panel). 
However, IL-32 was present after 24 h o f incubation with LPS 
(Figure 3A, middle lane) or M. tuberculosis (Figure 3A, lower 
lane). In addition, im m unohistochem istry o f the cytospins 
demonstrates that stim ulation by LPS or M. tuberculosis 
revealed a pattern o f IL-32 staining particularly associated  
with the cell membrane (Figure 3B, middle and right panels).
Monocytes Are the Source o f IL-32, but the Presence of 
Lymphocytes Increases IL-32 Production
PBMCs were separated into adherent monocytes, and non­
adherent lymphocytes, which were rem oved and cultured  
separately. When stimulated with M. tuberculosis or M. bovis 
BCG, m onocytes were the primary source o f IL-32, as 
dem onstrated by the significantly higher concentration of 
IL-32 in the cell lysates o f stimulated monocytes, compared 
with the lymphocytes (Figure 4A). However, com parison to 
the mixture o f m onocytes and lymphocytes in unfractionated  
PBMCs makes it clear that the presence o f lymphocytes 
potentiates the stim ulation o f IL-32 by the monocytes, and 
thus contributes significantly to the total production o f IL-32 
(Figure 4A). Each volunteer tested in the present study was 
PPD-negative, which rules out the influence o f lymphocytes 
due to antigen presentation o f mycobacteria to specific T 
cells.
To investigate the production o f IL-32 by differentiated  
monocytes, freshly obtained b lood m onocytes were cultured  
with 20% human serum to induce m acrophage-like cells, or 
with a com b in ation  o f  GM-CSF/IL-4 to obtain  a DC 
population . As shown in Figure 4B, m onocyte-derived  
macrophages and DCs produced approxim ately the same 
am ount o f IL-32 as freshly cultured adherent m onocytes (see 
Figure 4A). This was observed for both M. tuberculosis and M. 
bovis BCG stimulation.
IFNy Induces Production o f IL-32 in Primary Cells
As shown in Figure 5, PBMCs stim ulated with IFNy 
induced an 8-fold increase in IL-32. In contrast, IL -ip  or 
TNFa did not stimulate the production o f IL-32 in PBMCs, 
although these cytokines (similar to IFNy) are able to induce 
IL-32 in epithelial cells [1]. As a control, in the same PBMC 
cultures IL -ip  and TNFa induced chemokines and IL-6, 
whereas IFNy did not (data not shown). Therefore, it appears 
that IFNy is a highly selective IL-32-inducing cytokine for 
blood monocytes.
We have com pared the production o f IFNy induced by 
the various stimuli used for the induction o f IL-32 release. 
The highest amounts o f IFNy production were stimulated by 
M. tuberculosis (987 ±  185 pg/ml) and M. bovis BCG (794 6  
201 pg/ml), whereas LPS (217 ±  44 pg/ml), S. aureus (343 ±  
101 pg/ml), and C. albicans (197 ±  88 pg/ml) induced  
moderate amounts o f the cytokine. N o IFNy production  
was induced by Pam3Cys or poly I:C (data not shown). These 
data suggest that the induction o f IL-32 by mycobacteria 
and LPS may be at least in part m ediated by endogenous 
IFNy release.
In human PBMCs stimulated with heat-killed S. epidermidis 
or LPS, IFNy production is dependent on IL-18, since in the 
presence o f IL-18BP IFNy production is reduced by over 80% 
[12]. The role o f IL-18 in IFNy production by microbial 
products is dependent on processing and release o f IL-18 by 
caspase-1 [13,14]. As shown in Figure 5B, M. tuberculosis- 
induced IFNy production was reduced 80% by the neutral­
ization o f endogenous IL-18 by IL-18BP. In contrast, the 
production o f TNFa was unaffected by the neutralization of 
endogenous IL-18 (Figure 5B).
M. tuberculosis Stimulates IL-32 through a Caspase-1/IL- 
18/IFNy-Dependent Mechanism
As shown in Figure 6A, the production o f IL-32 in PBMCs 
stimulated with M. tuberculosis was reduced by 83% in the 
presence o f the caspase-1 inhibitor. U nder these same 
conditions IFNy levels were reduced by 77%, but TNFa 
production was unaffected by the inhibition o f caspase-1. To 
determ ine whether inhibition o f caspase-1 was reducing the 
activity o f endogenous IL-18 or IL-1P, the PBMCs were 
stimulated with M. tuberculosis in the presence o f their 
respective natural inhibitors, IL-18BP and IL-1Ra. As shown 
in Figure 6C, blocking IL-1 activity with saturating concen­
trations o f IL-1Ra had no effect on the production o f IL-32, 
IFNy, or TNFa, whereas IL-6 production was reduced by 
44% (p <  0.05; data not shown). As expected, in these same 
cultures, IL-18BP reduced both IL-32 (92% reduction) and 
IFNy (88% reduction), but not TNFa (Figure 6B). Although  
we observed that exogenous IFNy induced IL-32 in PBMCs 
(Figure 5A), in order to assess whether endogenous IFNy 
provided a similar signal, IFNy activity was neutralized with 
neutralizing anti-IFNy antibody. Blockade o f endogenous 
IFNy activity induced by M. tuberculosis strongly inhibited the 
production o f IL-32 (56% reduction; Figure 6D). N ot 
unexpectedly, reducing IFNy activity also moderately re­
duced TNFa synthesis, although this reduction did not reach 
statistical significance (Figure 6D). Collectively, these experi­
m ents dem onstrate that M. tuberculosis stim ulates the  
production o f IL-32 through a caspase-1/IL-18/IFNy path­
way.
PLoS Medicine | www.plosmedicine.org 1314 August 2006 | Volume 3 | Issue 8 | e277
IL-32 Induction by M. tuberculosis
%
Control LPS MTB
100ng/ml 1x10e7/ml
Figure 3. IL-32 Immunostaining o f Human PBMCs Stimulated with LPS or M. tuberculosis
(A) Freshly isolated PBMCs were left to adhere, stimulated with either control medium (first row), LPS (second row), or M. tuberculosis (MTB; third row), 
and 24 h later stained for the presence o f IL-32. Nuclei were stained with AMCA (blue, left panels), and IL-32 was stained with Cy3 (red, middle panels). 
The right panels show the merged pictures with WGA-stained cellular surface (green).The stained cells were examined by digital deconvoluted 
microscopy.
(B) PBMCs stimulated with control medium (left panel), LPS (middle panel), or M. tuberculosis (right panel) were stained with an anti-IL-32 monoclonal 
antibody and counterstained with Mayer's hematoxylin for optical microscopy.
DOI: 10.1371/journal.pmed.0030277.g003
Discussion
In the present study we demonstrate that mycobacteria 
species such as M. tuberculosis or M. bovis BCG are potent 
stimuli for the production o f the newly described proin- 
flammatory cytokine IL-32. Steady-state levels o f mRNA for 
IL-32 were present in freshly obtained b lood PBMCs in the 
absence o f culture or stimulants in healthy individuals, but 
also after 24 h o f incubation. LPS and M. tuberculosis increased  
steady-state levels o f IL-32 mRNA for isoforms a and y o f the 
cytokine. Although the ability o f LPS to induce the synthesis 
o f IL-32 was m oderate (3- to 4-fold increase), the mycobac­
teria M. tuberculosis and M. bovis BCG induced up to a 20-fold  
increase in IL-32 synthesis over PBMCs cultured in the 
absence o f mycobacteria. Furthermore, we dem onstrated that 
the increase in IL-32 production by mycobacteria is depend­
ent o f the proinflammatory pathway involving active IL-18 
induced by a caspase-1-dependent pathway. However, the 
role for IL-18 is primarily the production o f IFNy, which in 
turn stimulates IL-32. Indeed, neutralization o f endogenous
PLoS Medicine | www.plosmedicine.org
IFNy prevents M. tuberculosis-induced  IL-32, and culturing  
PBMCs with exogenous IFNy increases IL-32 production 10­
fold. We conclude that IFNy is the ultim ate m ediator o f IL-32 
synthesis induced by mycobacteria.
W hen PBMCs were stimulated with a large variety o f TLR 
agonists and heat-killed microorganisms, mycobacteria were 
the most potent in inducing the synthesis o f IL-32 in both  
whole b lood and freshly isolated PBMCs (Figure 1). O f the 
TLR agonists, only the TLR4 stimulus LPS was able to 
stim ulate m oderate p roduction  o f  IL-32 (3- to 4-fold  
increase). These data suggest that while LPS/TLR4 interaction  
can increase transcription o f IL-32 mRNA over that present 
in unstim ulated cells, a second signal for synthesis is provided  
specifically by m ycobacteria for the production  o f the 
protein. The specificity o f IL-32 stimulation by mycobacteria, 
but not other microorganisms, is clinically significant since 
IL-32 is an IFNy-inducible gene, and IFNy pathway defects 
are accom panied by an increased susceptibility to infection  
with low-virulent mycobacteria [6-8]. This specificity suggests 
a potential role o f IFNy-induced IL-32 in the host defense
1315 August 2006 | Volume 3 | Issue 8 | e277
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Figure 4. IL-32 Production by Monocytes, Macrophages, and DCs
(A) PBMCs were incubated for 2 h at 37 °C in 96-well plates, and non­
adherent lymphocytes were transferred to a different well. The total 
PBMCs, the adherent monocytes, or the non-adherent lymphocytes were 
stimulated with RPMI (hatched bars), M. tuberculosis (open bars), or M. 
bovis BCG (solid bars) for an additional 24 h. After 24 h, IL-32 
concentrations were measured.
(B) Adherent monocytes were incubated for 5 d with RPMI and 20% 
human serum for macrophage differentiation, or a combination of 50 ng/ 
ml GM-CSF and 20 ng/ml IL-4 for DC differentiation. The macrophages 
and DCs were thereafter stimulated for an additional 24 h with RPMI 
(hatched bars), M. tuberculosis (open bars), or M. bovis BCG (solid bars). IL- 
32 concentration was measured by ECL.
Data are presented as means ±  SEM (n =  8); *, p <  0.05; **, p <  0.01. 
DOI: 10.1371/journal.pmed.0030277.g004
Figure 5. IFNy Is a Stimulus of IL-32 Production
(A) PBMCs isolated from five volunteers were stimulated with IFNy, IL-1 p, 
or TNFa (all at a concentration of 10 ng/ml). IL-32 concentrations were 
measured by ECL 24 h later in cells lysed with Triton X-100.
(B) PBMCs were stimulated for 24 h with RPMI, M. tuberculosis (MTB), or 
M. tuberculosis in combination with 10 ig /m l IL-18BP. IFNy and TNFa 
concentrations were measured 24 h later.
Data are presented as means ±  SEM (n =  5); *, p <  0.05.
DOI: 10.1371/journal.pmed.0030277.g005
against m ycobacterial infections. The findings are also 
suggestive o f a role o f IL-32 in m ediating some o f the 
consequences o f mycobacterial stimulation. For example, we 
have reported that IL-32 synergizes specifically with the 
muram yldipeptide for IL-6 production [2]. The muramyldi- 
peptide is the minimal structure able to reproduce the 
adjuvant properties o f the mycobacterial cell wall, and IL-6 
plays a central role in this adjuvant activity [15].
IFNy induces IL-32 in epithelial cells [1], and we have 
observed a similar induction in PBMCs. Although other 
proinflammatory cytokines such as TNF and IL-1P induce IL- 
32 in epithelial cells [1], this was not observed in PBMCs 
(Figure 4). We investigated whether stimulation o f IL-32 by M. 
tuberculosis is indeed m ediated through synthesis o f endoge­
nous IFNy. Although the m onocyte is the primary source o f 
IL-32, lym phocytes are also required for optim al IL-32 
synthesis. It is well established that lymphocytes and natural 
killer cells are the two main cell populations involved in the 
production and release o f IFNy [16]. Stimulation o f IFNy by 
M . tuberculosis was dependent on intermediary production o f  
endogenous IL-18 (Figure 4), similarly to the stim ulation by 
other microorganisms [17]. Inhibition o f IL-18 processing by 
caspase-1, or neutralization o f IL-18 by IL-18BP, inhibited  
not only IFNy production, but also the induction o f IL-32 by
’ PLoS Medicine | www.plosmedicine.org
M. tuberculosis. Because caspase-1 also inhibits processing o f 
pro-IL-ip into an active mature form, it was necessary to 
exclude a role for endogenous IL-ip in the effects o f the 
caspase-1 inhibitor. Unlike for IL-18, blockade o f IL-1 by IL- 
lR a had no effect on M. tuberculosis-induced IL-32 produc­
tion. The fact that IL-32 stim ulation by M. tuberculosis was 
m ediated by the release o f endogenous IFNy was further 
dem onstrated by the blockade o f IL-32 synthesis by a 
neutralizing antibody to IFNy. Thus, the chain o f events 
leading to stim ulation o f IL-32 by M. tuberculosis involves 
caspase-1-dependent IL-18 from monocytes, which stimulates 
production o f IFNy from lymphocytes. IFNy, in turn, drives 
the translational m achinery for IL-32 synthesis in the 
m onocytes and macrophages.
Steady-state levels o f mRNA coding for IL-32P, IL-32y, and 
IL-32d are clearly present in freshly obtained PBMCs, whereas 
gene expression for IL-32a is barely detectable; importantly, 
there is no detectable IL-32 protein in the lysates o f these 
cells. IL-32 mRNA o f isoforms a and y was stimulated by both  
LPS and M. tuberculosis, while isoform P was quite strongly 
expressed in steady-state unstim ulated cells, and was not 
further induced by stimulation. In contrast, IL-32 mRNA 
isoform d expression was heterogenous, both in terms o f basal 
steady-state expression and response to stimulation. Even
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Figure 6. M. tuberculosis Stimulates IL-32 through a Caspase-1/IL-18/IFNy-Dependent Mechanism
PBMCs were stimulated with RPMI, M. tuberculosis (MTB), or a combination o f M. tuberculosis and cytokine inhibitors: 20 iM  o f a caspase-1 inhibitor 
(casp-1inh) (A), 10 ig /m l IL-18BP (B), IL-1Ra (C), or 10 ig /m l o f a monoclonal mouse anti-human IFNy antibody (D). As a control for the anti-IFNy 
antibody, a similar concentration of a purified mouse IgG1 antibody was used in the control stimulation. After 24 h of incubation, IL-32, IFNy, and TNF 
concentrations were measured by ECL. The dashed line represents the 100% stimulation induced by M. tuberculosis alone. The open bars represent the 
unstimulated cells, and the solid bars represent the cells stimulated with M. tuberculosis in the presence of the cytokine inhibitors, expressed as percent 
of M. tuberculosis production. Data are presented as means ±  SEM (n =  8); *, p <  0.05.
DOI: 10.1371/journal.pmed.0030277.g006
after 24 h o f culture on a plastic surface, there was no IL-32 
protein in the lysates. However, upon stimulation with LPS 
and mycobacteria, IL-32 protein concentration rose 4-fold 
and 20-fold, respectively. Since the ECL m ethod for detecting  
IL-32 does not distinguish between the different isoforms, the 
IL-32 protein in the lysates could be due to any one o f the 
isoforms.
The dissociated expression o f the IL-32 gene and synthesis 
o f the cytokine itself is rem iniscent o f the dissociation o f IL- 
1P gene expression and synthesis in PBMCs. In studies o f IL- 
1P expression, adherence to glass or plastic in the strict 
absence o f  en d otoxins or other m icrobial agents was 
sufficient for IL-1P gene expression, but not for the trans­
lation  in to  the IL-1P precursor [18]. Even using the 
inflammatory C5a com plem ent com ponent, human PBMCs 
exhibit the same levels o f IL-1P and TNFa gene expression as 
those induced with LPS [19] but, in the case o f C5a 
stimulation, w ithout detectable translation o f IL-1P or TNFa 
[19]. In those studies, there was no failure o f mRNA coding o f 
IL-1P to associate with large polysomes and initiate trans­
lation [20]; in fact, evidence revealed that initiation of 
translation was intact [20]. However, adherence to glass and 
plastic surfaces or stim ulation by C5a was not sufficient to 
com plete the translation into the IL-1P precursor. The failure 
to com plete translation appeared to be due to early 
term ination o f elongation o f the polypeptide [20]. LPS or 
IL-1P itself at exceedingly low concentrations provide the 
intracellular com ponents to com plete the translation [19]. It 
is presently unknown whether mRNA coding for IL-32a, IL- 
32P, IL-32y, or IL-32S is similarly incapable o f com pleting  
translation or whether binding to the ribosom e is defective. 
However, the data in the present study suggest that unlike
PLoS Medicine | www.plosmedicine.org
most mRNA coding for cytokines, IL-32 mRNA belongs to the 
class o f proinflammatory cytokines that are regulated unless a 
second  signal is provided. In addition , stronger IFNy 
stimulation by mycobacteria com pared to other stimuli could  
also have played a role in the differential stim ulation o f IL-32. 
However, IFNy and IL-32 production were not com pletely  
correlated, as some microorganisms such as S. aureus or C. 
albicans induced IFNy production, yet they were incapable of 
stimulating IL-32 release. In this respect, the release of 
intermediary IFNy seems to be a necessary, but not sufficient, 
step in the induction o f IL-32.
Corroborating these findings is the absence o f IL-32 
protein in adherent blood m onocytes cultured for 24 h and 
exam ined by im m unostaining with an anti-human IL-32 
m onoclonal antibody. The absence o f IL-32 protein em ploy­
ing either an affinity-purified goat anti-human IL-32a anti­
body or the m onoclonal antibody supports the concept that 
IL-32 gene expression can exist without translation into IL-32 
protein. The m onoclonal antibody’s ability to detect IL-32 
was apparent follow ing stim ulation with LPS or M. tuberculosis. 
There was staining for IL-32 on the cells’ surface and 
measurable IL-32 in the lysates o f these cells. The staining  
o f IL-32 in the confocal microscopy was comparable to the 
diffuse cytosolic staining patterns seen for IL-1a and IL -ip  in 
LPS-stim ulated m onocytes [21]. H owever, the localized  
im m unohistochem ical staining o f the cell membrane after 
stimulation with LPS or M. tuberculosis suggests that IL-32 is a 
cell-associated cytokine, similar to other cytokines such as IL- 
1a or lym photoxin-a [22,23].
Both IL-32 (all isoforms) and IL -ip  lack a classic signal 
peptide. Therefore, it is not unexpected that in stimulated 
blood m onocytes there is no detectable IL-32 in the super­
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natant whereas the cell lysates contain nearly all o f the 
measurable IL-32. Because LPS and M. tuberculosis stimulate 
caspase-1 cleavage o f IL-1P, the lack o f secreted IL-32 is 
consistent with the absence o f a caspase-1 site in any o f the 
isoforms o f IL-32. In fact, the decrease in IL-32 synthesis in 
the presence o f a caspase-1 inhibitor is not a direct effect o f 
caspase-1 on IL-32 but rather on IL -18-induced IFNy 
production. In addition, there is no structural relationship  
betw een  m em bers o f the IL-1 fam ily and IL-32, also 
supporting the absence o f caspase-1 cleavage sites in IL-32.
Several cytokines and growth factors lack a clear signal 
peptide and are not secreted, but nevertheless play a role in 
the pathogenesis o f  disease. For exam ple, IL-1a is not 
secreted from  m onocytes follow ing stim ulation by LPS and 
other TLR agonists, despite the presence o f large intracellular 
stores. Yet, IL-1a plays an im portant role in im m une 
responses to specific antigens. Comparing m ice deficient in 
IL-1a or IL-1P, IL-1a but not IL-1P was required for contact- 
allergen-specific T cell activation during the sensitization  
phase in contact hypersensitivity [24]. In addition, macro­
phages o f m ice deficient in IL-1a display defective phagocy­
tosis and killing o f C. albicans, which contributes to their 
increased susceptibility to dissem inated infections in these 
mice (A. G. Vonk, M. G. Netea, J. H. van Krieken, Y. Iwakura, 
J. W. van der Meer, et al., unpublished data). Similarly, 
m em brane-bound TNFa plays an im portant role in the 
pathogenesis o f tuberculosis [25]. A nother cytokine, acidic 
fibroblast growth factor also lacks a signal peptide and is 
found primarily in the cytosol. Yet, acidic fibroblast growth 
factor plays an im portant role in neural cell growth [26]. 
Similarly, although IL-32 appears to be mainly a cell- 
associated cytokine, its proinflammatory properties suggest 
im portant effects on inflamm ation and host defense.
An im portant issue relevant to the present study is the 
identity o f the pattern-recognition receptors that trigger the 
translation the o f IL-32 mRNA following stim ulation with 
mycobacteria. The induction o f IL-32 by LPS suggests that 
TLR4 may be involved, and this is consistent with the studies 
showing a role o f TLR4 in the recognition o f mycobacteria 
[27]. However, TLR4 alone is unlikely to be the sole pathway 
n eeded  for IL-32 stim ulation , given the less effic ien t 
induction o f IL-32 by LPS com pared with M. tuberculosis and 
M. bovis BCG. It is therefore likely that a secondary pathway is 
activated by mycobacteria, which is needed in com bination  
with TLR4 stim ulation for the induction o f IL-32. Further 
studies are needed to elucidate this aspect.
In conclusion, the results o f the present study give several 
im portant insights into the b iology o f  IL-32. Firstly, 
m ycobacteria species induce production  o f  IL-32 from  
human m onocytes and macrophages, while other m icro­
organisms such as S. aureus and the fungal pathogens C. 
albicans and A. fumigatus do not. Secondly, this capacity of 
mycobacteria to stimulate IL-32 is m ediated by their capacity 
to induce IFNy, a crucial cytokine o f host defense against 
these microorganisms. Furthermore, IL-32 is a cell-associated  
cytokine, and in this form  may exert its proinflammatory 
effects.
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Editors' Summary
Background. Tuberculosis (TB) is a serious infectious disease that is 
becoming more common. Worldwide it causes around 2 million deaths 
every year, mostly in developing countries. Some 2 billion people—or 
one-third o f the world's population—are chronically infected without 
active symptoms. In humans the disease is usually caused by a bacterium 
called Mycobacterium tuberculosis. Another related bacterium, Mycobac­
terium bovis, causes TB in cattle and sometimes in people.
The immune system, which defends the body against infections, 
involves a number o f cells (for example, the white blood cells) and also 
chemicals. People with defects in their immune system are more likely to 
suffer from infectious diseases. Cytokines are one class of chemicals in 
the immune system. A particular cytokine called interleukin-32 (IL-32) has 
been shown to play a role in the development of inflammation, which is 
a part o f the body's response to infection. Previous research has 
suggested that IL-32 might be o f particular importance in the defenses 
against TB. In recent years scientists have discovered a lot about the 
processes involved in the ‘‘switching on’’ o f the individual parts o f the 
immune system in response to infection. However, very little is known 
about the factors influencing the switching on of production o f IL-32.
Why Was This Study Done? It would be useful to know more about the 
production of IL-32 because it would advance understanding of the 
immune system in general and, more specifically, how the body protects 
itself against bacteria, such as those that cause TB.
W hat Did the Researchers Do and Find? Working with eight healthy 
volunteers, the researchers took white blood cells of a particular type 
(peripheral blood mononuclear cells) and exposed them to substances 
known as TLR agonists. Toll-like receptors (TLRs) are receptors on the 
surface o f leukocytes that recognize specific components of micro­
organisms. Upon recognition of these microbial components, which 
function as TLR stimuli (or TLR agonists), signals are transmitted that 
activate the immune system and thus the host defense. Using a complex 
series of laboratory procedures, they found that one type of TLR agonist 
(known as LPS) produced a big increase in IL-32 production, whereas all 
the other types of TLR agonists that they used produced only small 
increases. The researchers tested M. tuberculosis and M. bovis bacteria to 
see whether they increased IL-32 production and they found that they 
did so, to a greater degree even than LPS. The researchers also learned 
other details about IL-32 and the pathway of chemical changes that 
eventually leads to its production.
W hat Do These Findings Mean? The researchers say their study 
provides several important insights into the biology of IL-32. The findings 
confirm that IL-32 is an important factor in the body's defenses against 
TB. This information will help in understanding how the disease spreads 
and who is most vulnerable to it. Ultimately, it may assist in the search 
for new ways o f treating and preventing the disease.
Add itiona l In form ation. Please access these Web sites via the online 
version o f this summary at http://dx.doi.org/10.1371/journal.pmed. 
0030277.
•  The online encyclopedia Wikipedia has useful information on 
tuberculosis
•  Wikipedia also has useful information on the immune system
•  More detailed information about international efforts to control TB 
may be found at the Web sites of the International Union Against 
Tuberculosis and Lung Disease and the World Health Organization's 
Stop TB Department
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